UnknownNCT06505668
Effect of Atenolol Versus Ivabradine on HRV in TRS Patients on Clozapine With Tachycardia: A Randomised Control Trial.
Medication studyAges 18–60IndiaSchizophrenia
Understand this study
Who could participate?
Listed age limits: 18 years to 60 years.
- Listed locations
- BhubaneswarSee all locations and recruitment
What to know before participating
A point to clarify
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
Study start dateStarted: August 1, 2023
- Recruitment status
- Unknown
- Enrollment listed in the registry
- 40
- Sponsor
- All India Institute of Medical Sciences, Bhubaneswar
- Sponsor type
- Research institute
- Study type
- Drug
- Intervention type
- Drug
- Locations
- India
- Age range
- From 18 Years to 60 Years
- Official registry ID
- NCT06505668
- Official title
Show the full official title
Effect Of Atenolol Versus Ivabradine On Heart Rate Variability In Treatment Resistant Schizophrenia Patients On Clozapine With Tachycardia: A Randomized Control Trial.
Recruitment & locations
Status unknownThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Bhubaneswar
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is All India Institute of Medical Sciences, Bhubaneswar, a research institute.
Does this study involve medication?
Yes. The study involves medication, including Atenolol 25 mg and Ivabradine 10mg.
Who can participate?
Listed age limits: 18 years to 60 years.
